LINAGLIPTIN

LINAGLIPTIN was reported 18486 times

These side effects are most commonly reported by patients taking LINAGLIPTIN:

# Side effect Count
0 BLOOD GLUCOSE INCREASED 1385
1 DIARRHOEA 1322
2 NAUSEA 1241
3 FATIGUE 1098
4 DYSPNOEA 1060
5 OFF LABEL USE 1019
6 DIZZINESS 997
7 VOMITING 976
8 ACUTE KIDNEY INJURY 860
9 MALAISE 843
10 HEADACHE 810
11 PRURITUS 788
12 ARTHRALGIA 778
13 PYREXIA 758
14 PAIN 702
15 DRUG INEFFECTIVE 682
16 DEHYDRATION 658
17 ABDOMINAL PAIN UPPER 647
18 BACK PAIN 646
19 CHEST PAIN 623
20 PERIPHERAL SWELLING 613
21 ABDOMINAL DISCOMFORT 599
22 COVID-19 599
23 FALL 589
24 MYOCARDIAL INFARCTION 578
25 DEATH 575
26 INSOMNIA 574
27 ANXIETY 571
28 RASH 550
29 MUSCULAR WEAKNESS 545
30 FEELING ABNORMAL 538
31 PALPITATIONS 533
32 ALOPECIA 521
33 ASTHENIA 521
34 HYPERHIDROSIS 521
35 VISUAL IMPAIRMENT 515
36 RENAL FAILURE 509
37 MEMORY IMPAIRMENT 498
38 TACHYCARDIA 493
39 HEART RATE INCREASED 485
40 PNEUMONIA 484
41 HALLUCINATION 468
42 CHRONIC KIDNEY DISEASE 466
43 DRY SKIN 466
44 WEIGHT DECREASED 454
45 BLINDNESS 451
46 SUBARACHNOID HAEMORRHAGE 450
47 ANGIOEDEMA 448
48 AMNESIA 444
49 LIP SWELLING 441
50 TRANSIENT ISCHAEMIC ATTACK 438
51 VENTRICULAR TACHYCARDIA 432
52 INTENTIONAL PRODUCT MISUSE 431
53 DECREASED APPETITE 426
54 HYPOGLYCAEMIA 426
55 MIGRAINE 424
56 COGNITIVE DISORDER 422
57 TINNITUS 412
58 DISTURBANCE IN ATTENTION 407
59 EYE PRURITUS 400
60 CAROTID ARTERY OCCLUSION 399
61 VASCULITIS 399
62 PERICARDITIS 398
63 ATRIAL TACHYCARDIA 396
64 MUSCLE TWITCHING 396
65 DIPLOPIA 395
66 CARDIOSPASM 394
67 PRURITUS GENITAL 393
68 ANOSMIA 392
69 TENSION HEADACHE 392
70 FACIAL PAIN 391
71 PAIN OF SKIN 391
72 PALMOPLANTAR KERATODERMA 388
73 SLEEP TERROR 387
74 INTENTIONAL PRODUCT USE ISSUE 374
75 URINARY TRACT INFECTION 355
76 HYPOTENSION 349
77 ABDOMINAL PAIN 343
78 PANCREATITIS 332
79 CONSTIPATION 328
80 RENAL IMPAIRMENT 316
81 PAIN IN EXTREMITY 306
82 COUGH 305
83 DRUG INTERACTION 299
84 GLYCOSYLATED HAEMOGLOBIN INCREASED 298
85 RASH PAPULAR 283
86 ANAEMIA 278
87 HYPERTENSION 259
88 PEMPHIGOID 258
89 IMMUNISATION 257
90 HYPERGLYCAEMIA 255
91 CARDIAC FAILURE 254
92 CONDITION AGGRAVATED 252
93 HYPERKALAEMIA 249
94 BLOOD PRESSURE INCREASED 242
95 OEDEMA PERIPHERAL 242
96 LACTIC ACIDOSIS 241
97 DERMATITIS BULLOUS 235
98 DIABETES MELLITUS 231
99 GAIT DISTURBANCE 221
100 CONFUSIONAL STATE 219
101 METABOLIC ACIDOSIS 219
102 CEREBROVASCULAR ACCIDENT 216
103 TOXICITY TO VARIOUS AGENTS 214
104 WEIGHT INCREASED 214
105 HAEMOGLOBIN DECREASED 212
106 SYNCOPE 208
107 SEPSIS 197
108 BLOOD CREATININE INCREASED 192
109 SOMNOLENCE 191
110 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 185
111 BLOOD GLUCOSE DECREASED 183
112 MYALGIA 178
113 MUSCLE SPASMS 174
114 TREMOR 168
115 PRODUCT USE ISSUE 167
116 URTICARIA 167
117 ATRIAL FIBRILLATION 166
118 BLOOD GLUCOSE ABNORMAL 165
119 CARDIAC FAILURE CONGESTIVE 165
120 ADVERSE DRUG REACTION 159
121 JOINT SWELLING 157
122 ERYTHEMA 155
123 NASOPHARYNGITIS 148
124 DIABETIC KETOACIDOSIS 142
125 END STAGE RENAL DISEASE 140
126 RENAL DISORDER 140
127 PLATELET COUNT DECREASED 136
128 PRODUCT DOSE OMISSION ISSUE 136
129 DEPRESSION 133
130 HYPERSENSITIVITY 130
131 INJECTION SITE PAIN 130
132 LETHARGY 130
133 LOSS OF CONSCIOUSNESS 130
134 BLOOD PRESSURE DECREASED 129
135 OROPHARYNGEAL PAIN 127
136 HYPOAESTHESIA 126
137 ABDOMINAL DISTENSION 122
138 GASTROINTESTINAL HAEMORRHAGE 122
139 GASTROOESOPHAGEAL REFLUX DISEASE 121
140 NEUROPATHY PERIPHERAL 121
141 CHEST DISCOMFORT 120
142 DIABETES MELLITUS INADEQUATE CONTROL 117
143 PARAESTHESIA 116
144 VISION BLURRED 116
145 DYSPHAGIA 114
146 INFECTION 114
147 CATARACT 113
148 BLISTER 110
149 WHITE BLOOD CELL COUNT DECREASED 109
150 GENERAL PHYSICAL HEALTH DETERIORATION 106
151 HYPONATRAEMIA 106
152 INCORRECT DOSE ADMINISTERED 106
153 OEDEMA 106
154 PRODUCT USE IN UNAPPROVED INDICATION 106
155 GASTROINTESTINAL DISORDER 105
156 OVERDOSE 105
157 PLEURAL EFFUSION 104
158 DRUG DOSE OMISSION 103
159 THROMBOCYTOPENIA 103
160 PANCREATIC CARCINOMA 102
161 DELIRIUM 101
162 BRADYCARDIA 100
163 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 98
164 INFLUENZA 97
165 ACUTE MYOCARDIAL INFARCTION 96
166 CARDIAC DISORDER 96
167 PANCREATITIS ACUTE 95
168 EPISTAXIS 94
169 FEBRILE NEUTROPENIA 94
170 MUSCULOSKELETAL STIFFNESS 93
171 TUBULOINTERSTITIAL NEPHRITIS 93
172 HOSPITALISATION 92
173 ILLNESS 92
174 SEPTIC SHOCK 92
175 MEDICATION ERROR 91
176 CELLULITIS 90
177 DYSPEPSIA 90
178 RHABDOMYOLYSIS 90
179 SINUSITIS 89
180 CARDIAC ARREST 88
181 FLUID RETENTION 87
182 DISEASE PROGRESSION 86
183 NEPHROLITHIASIS 85
184 PRODUCTIVE COUGH 85
185 RED BLOOD CELL COUNT DECREASED 85
186 RESPIRATORY FAILURE 85
187 EUGLYCAEMIC DIABETIC KETOACIDOSIS 84
188 RECTAL HAEMORRHAGE 84
189 BLOOD PRESSURE SYSTOLIC INCREASED 83
190 MOBILITY DECREASED 83
191 OXYGEN SATURATION DECREASED 83
192 PULMONARY EMBOLISM 83
193 RHINORRHOEA 81
194 SWELLING 81
195 ASPARTATE AMINOTRANSFERASE INCREASED 80
196 NEPHROGENIC ANAEMIA 80
197 GLOMERULAR FILTRATION RATE DECREASED 79
198 NEUTROPENIA 79
199 CHOLELITHIASIS 78
200 DYSGEUSIA 78
201 FLATULENCE 78
202 HAEMATURIA 78
203 BALANCE DISORDER 76
204 INTESTINAL OBSTRUCTION 76
205 PULMONARY OEDEMA 76
206 THROMBOSIS 75
207 ASTHMA 74
208 BRONCHITIS 74
209 CORONARY ARTERY DISEASE 74
210 SEIZURE 74
211 HYPOPHAGIA 73
212 BLOOD CHOLESTEROL INCREASED 72
213 BLOOD POTASSIUM DECREASED 72
214 PERICARDIAL EFFUSION 72
215 SHOCK 72
216 BLOOD POTASSIUM INCREASED 71
217 HAEMATOCRIT DECREASED 71
218 HEAD INJURY 71
219 DRUG HYPERSENSITIVITY 70
220 MOVEMENT DISORDER 70
221 OSTEOPOROSIS 70
222 RENAL INJURY 70
223 ARTHRITIS 69
224 BURNING SENSATION 69
225 CONTUSION 69
226 DRUG INTOLERANCE 69
227 DRY MOUTH 69
228 MALIGNANT NEOPLASM PROGRESSION 69
229 CARDIOMEGALY 67
230 DEMENTIA 67
231 HYPOVOLAEMIA 67
232 RASH PRURITIC 67
233 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 67
234 TYPE 2 DIABETES MELLITUS 67
235 DEPRESSED LEVEL OF CONSCIOUSNESS 66
236 INTERSTITIAL LUNG DISEASE 66
237 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 65
238 SKIN DISORDER 65
239 STRESS 65
240 VERTIGO 65
241 WHEEZING 65
242 ARRHYTHMIA 64
243 SLEEP DISORDER 64
244 SWELLING FACE 64
245 PRODUCT QUALITY ISSUE 63
246 SKIN EXFOLIATION 63
247 WHITE BLOOD CELL COUNT INCREASED 63
248 BLOOD UREA INCREASED 62
249 CHILLS 62
250 ELECTROCARDIOGRAM QT PROLONGED 62
251 IMPAIRED GASTRIC EMPTYING 62
252 LIMB DISCOMFORT 62
253 MELAENA 62
254 NASAL CONGESTION 62
255 RASH ERYTHEMATOUS 62
256 HAEMORRHAGE 61
257 HYPOKALAEMIA 61
258 POLLAKIURIA 61
259 UNDERDOSE 61
260 DRUG ABUSE 60
261 HYPOACUSIS 60
262 HYPOXIA 60
263 HEPATIC FUNCTION ABNORMAL 59
264 URINARY INCONTINENCE 59
265 GOUT 58
266 HYPOMAGNESAEMIA 58
267 SKIN DISCOLOURATION 58
268 SKIN ULCER 58
269 ILL-DEFINED DISORDER 56
270 LEFT VENTRICULAR DYSFUNCTION 56
271 SKIN LESION 56
272 SPUTUM DISCOLOURED 56
273 UNEVALUABLE EVENT 56
274 BLOOD PRESSURE FLUCTUATION 55
275 DYSURIA 55
276 NECK PAIN 55
277 CLOSTRIDIUM DIFFICILE INFECTION 54
278 FAECES DISCOLOURED 54
279 INFLAMMATION 54
280 C-REACTIVE PROTEIN INCREASED 53
281 CEREBRAL INFARCTION 53
282 DRUG-INDUCED LIVER INJURY 53
283 INTENTIONAL OVERDOSE 53
284 RALES 53
285 DYSPHONIA 52
286 HEART RATE IRREGULAR 52
287 HEPATIC STEATOSIS 52
288 URINARY RETENTION 52
289 DRUG LEVEL INCREASED 51
290 FUNGAL INFECTION 51
291 HAEMORRHOIDS 51
292 OSTEOARTHRITIS 51
293 ALANINE AMINOTRANSFERASE INCREASED 50
294 BLOOD TRIGLYCERIDES INCREASED 50
295 CYSTITIS 50
296 JAUNDICE 50
297 STOMATITIS 50
298 ANGINA PECTORIS 49
299 BLOOD IRON DECREASED 49
300 ECZEMA 49
301 GAMMA-GLUTAMYLTRANSFERASE INCREASED 49
302 HAEMATOCHEZIA 49
303 MUSCULOSKELETAL PAIN 49
304 BLOOD GLUCOSE FLUCTUATION 48
305 DYSPNOEA EXERTIONAL 48
306 EJECTION FRACTION DECREASED 48
307 LYMPHOCYTE COUNT DECREASED 48
308 MULTIPLE ORGAN DYSFUNCTION SYNDROME 48
309 PROTEINURIA 48
310 NEOPLASM MALIGNANT 47
311 PNEUMONIA ASPIRATION 47
312 PSORIASIS 47
313 RHEUMATOID ARTHRITIS 47
314 DEPRESSED MOOD 46
315 HAEMATOMA 46
316 NEPHROPATHY 46
317 UPPER RESPIRATORY TRACT INFECTION 46
318 ABNORMAL LOSS OF WEIGHT 45
319 LEUKOCYTOSIS 45
320 THERAPY INTERRUPTED 45
321 ALTERED STATE OF CONSCIOUSNESS 44
322 CARDIO-RESPIRATORY ARREST 44
323 HEPATIC FAILURE 44
324 HERPES ZOSTER 44
325 HYPERLACTACIDAEMIA 44
326 INFLUENZA LIKE ILLNESS 44
327 BLADDER CANCER 43
328 DISCOMFORT 43
329 EXPIRED PRODUCT ADMINISTERED 43
330 FOURNIER^S GANGRENE 43
331 HYPERPARATHYROIDISM SECONDARY 43
332 INCORRECT PRODUCT ADMINISTRATION DURATION 43
333 KIDNEY INFECTION 43
334 LIMB INJURY 43
335 PANCYTOPENIA 43
336 CLOSTRIDIUM DIFFICILE COLITIS 42
337 LOWER RESPIRATORY TRACT INFECTION 42
338 MITRAL VALVE INCOMPETENCE 42
339 ORTHOSTATIC HYPOTENSION 42
340 PULMONARY MASS 42
341 BREAST CANCER METASTATIC 41
342 PRESYNCOPE 41
343 PYELONEPHRITIS 41
344 SLEEP APNOEA SYNDROME 41
345 TRICUSPID VALVE INCOMPETENCE 41
346 EYE PAIN 40
347 HEPATIC ENZYME INCREASED 40
348 HOT FLUSH 40
349 INTERNATIONAL NORMALISED RATIO INCREASED 40
350 LUNG DISORDER 40
351 PRODUCT PRESCRIBING ERROR 40
352 THERAPY CESSATION 40
353 THIRST 40
354 ASCITES 39
355 DYSARTHRIA 39
356 PNEUMONITIS 39
357 UNRESPONSIVE TO STIMULI 39
358 DEEP VEIN THROMBOSIS 38
359 INJECTION SITE MASS 38
360 LEUKOPENIA 38
361 NERVOUSNESS 38
362 SUPRAVENTRICULAR TACHYCARDIA 38
363 AGITATION 37
364 BONE PAIN 37
365 COMPLETED SUICIDE 37
366 GASTRITIS 37
367 INJECTION SITE ERYTHEMA 37
368 LIVER DISORDER 37
369 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 37
370 UPPER GASTROINTESTINAL HAEMORRHAGE 37
371 ARTERIOSCLEROSIS CORONARY ARTERY 36
372 BLOOD CREATINE PHOSPHOKINASE INCREASED 36
373 FEELING HOT 36
374 FLANK PAIN 36
375 HAEMODYNAMIC INSTABILITY 36
376 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 36
377 INJECTION SITE HAEMORRHAGE 36
378 LOCALISED INFECTION 36
379 NEUTROPHIL COUNT DECREASED 36
380 OSTEOMYELITIS 36
381 PRODUCT DOSE OMISSION 36
382 BUNDLE BRANCH BLOCK LEFT 35
383 CEREBRAL HAEMORRHAGE 35
384 EOSINOPHILIA 35
385 HAEMOGLOBIN INCREASED 35
386 NOCTURIA 35
387 SPEECH DISORDER 35
388 BLOOD PRESSURE DIASTOLIC DECREASED 34
389 CAROTID ARTERY STENOSIS 34
390 CONTRAINDICATED PRODUCT ADMINISTERED 34
391 DYSKINESIA 34
392 HAEMATEMESIS 34
393 INJECTION SITE SWELLING 34
394 IRRITABILITY 34
395 OCULAR HYPERAEMIA 34
396 PULMONARY CONGESTION 34
397 RASH GENERALISED 34
398 SCIATICA 34
399 THERAPEUTIC RESPONSE UNEXPECTED 34
400 VENTRICULAR ARRHYTHMIA 34
401 BLOOD BILIRUBIN INCREASED 33
402 BODY TEMPERATURE DECREASED 33
403 BREAST CANCER 33
404 DRUG ERUPTION 33
405 GAIT INABILITY 33
406 HYPERLIPIDAEMIA 33
407 HYPOCALCAEMIA 33
408 HYPOGLYCAEMIC COMA 33
409 NEOPLASM 33
410 NEUROTOXICITY 33
411 STEVENS-JOHNSON SYNDROME 33
412 TOXIC EPIDERMAL NECROLYSIS 33
413 WOUND 33
414 ACUTE RESPIRATORY FAILURE 32
415 BLOOD PRESSURE ABNORMAL 32
416 DEVICE ISSUE 32
417 FLUSHING 32
418 LIPASE INCREASED 32
419 PROTEIN URINE PRESENT 32
420 ROAD TRAFFIC ACCIDENT 32
421 SUICIDE ATTEMPT 32
422 TREATMENT NONCOMPLIANCE 32
423 URINE OUTPUT DECREASED 32
424 ASPIRATION 31
425 DIALYSIS 31
426 DIASTOLIC DYSFUNCTION 31
427 DYSSTASIA 31
428 EMOTIONAL DISTRESS 31
429 INCONTINENCE 31
430 INJURY 31
431 KETOACIDOSIS 31
432 NEEDLE ISSUE 31
433 NO ADVERSE EVENT 31
434 PULMONARY HYPERTENSION 31
435 RETCHING 31
436 VULVOVAGINAL MYCOTIC INFECTION 31
437 ANAPHYLACTIC REACTION 30
438 CORONARY ARTERY STENOSIS 30
439 GENERALISED OEDEMA 30
440 HEART RATE DECREASED 30
441 HEPATIC NEOPLASM 30
442 INJECTION SITE PRURITUS 30
443 OBSTRUCTIVE AIRWAYS DISORDER 30
444 PLASMA CELL MYELOMA 30
445 POLYURIA 30
446 RESPIRATORY TRACT INFECTION 30
447 SWOLLEN TONGUE 30
448 VISUAL ACUITY REDUCED 30
449 AORTIC VALVE INCOMPETENCE 29
450 APHASIA 29
451 CLOSTRIDIUM TEST POSITIVE 29
452 ENCEPHALOPATHY 29
453 GASTROENTERITIS 29
454 GASTROENTERITIS VIRAL 29
455 HEPATIC CIRRHOSIS 29
456 LOW DENSITY LIPOPROTEIN DECREASED 29
457 NERVE INJURY 29
458 PRURITUS GENERALISED 29
459 ACCIDENTAL OVERDOSE 28
460 ANGIOPATHY 28
461 BLOOD MERCURY ABNORMAL 28
462 BLOOD SODIUM DECREASED 28
463 BLOOD SODIUM INCREASED 28
464 CHROMATURIA 28
465 COLITIS 28
466 DISORIENTATION 28
467 HIP FRACTURE 28
468 LEFT VENTRICULAR HYPERTROPHY 28
469 MUSCULOSKELETAL CHEST PAIN 28
470 PALLOR 28
471 PERICARDIAL DISEASE 28
472 VENTRICULAR HYPOKINESIA 28
473 VIRAL INFECTION 28
474 BLOOD PHOSPHORUS INCREASED 27
475 CHOLECYSTITIS 27
476 CYTOMEGALOVIRUS INFECTION 27
477 DIABETIC FOOT 27
478 DIABETIC NEUROPATHY 27
479 DISSEMINATED INTRAVASCULAR COAGULATION 27
480 EYE IRRITATION 27
481 GANGRENE 27
482 LABORATORY TEST ABNORMAL 27
483 LIVER FUNCTION TEST ABNORMAL 27
484 LUNG NEOPLASM MALIGNANT 27
485 NEPHROPATHY TOXIC 27
486 PARKINSONISM 27
487 SUBDURAL HAEMATOMA 27
488 UROSEPSIS 27
489 ABDOMINAL PAIN LOWER 26
490 ADRENAL INSUFFICIENCY 26
491 ADVERSE EVENT 26
492 AGEUSIA 26
493 AGRANULOCYTOSIS 26
494 ANKLE FRACTURE 26
495 BLOOD CREATINE INCREASED 26
496 DIVERTICULITIS 26
497 EAR INFECTION 26
498 ELECTROCARDIOGRAM ABNORMAL 26
499 HAEMOPTYSIS 26
500 JOINT INJURY 26
501 MALNUTRITION 26
502 PANCREATITIS HAEMORRHAGIC 26
503 RASH MACULAR 26
504 RIB FRACTURE 26
505 STAPHYLOCOCCAL INFECTION 26
506 SURGERY 26
507 TACHYPNOEA 26
508 THERAPEUTIC RESPONSE DECREASED 26
509 THROAT TIGHTNESS 26
510 VITAMIN B12 DECREASED 26
511 VITAMIN B12 DEFICIENCY 26
512 ABNORMAL BEHAVIOUR 25
513 AGGRESSION 25
514 ATRIOVENTRICULAR BLOCK 25
515 AZOTAEMIA 25
516 CORONARY ARTERY OCCLUSION 25
517 COVID-19 PNEUMONIA 25
518 EATING DISORDER 25
519 HIATUS HERNIA 25
520 ORAL CANDIDIASIS 25
521 PULMONARY VALVE DISEASE 25
522 RENAL TUBULAR NECROSIS 25
523 SOPOR 25
524 THROMBOTIC MICROANGIOPATHY 25
525 TOXIC ENCEPHALOPATHY 25
526 APRAXIA 24
527 BLOOD ALKALINE PHOSPHATASE INCREASED 24
528 BLOOD COUNT ABNORMAL 24
529 BLOOD LACTATE DEHYDROGENASE INCREASED 24
530 BLOOD LACTIC ACID INCREASED 24
531 CAROTID ARTERIOSCLEROSIS 24
532 DYSPNOEA AT REST 24
533 EXTRA DOSE ADMINISTERED 24
534 FEMUR FRACTURE 24
535 GASTRIC ULCER 24
536 HELICOBACTER GASTRITIS 24
537 HYPOTHYROIDISM 24
538 INTERNAL HAEMORRHAGE 24
539 INTERVERTEBRAL DISC PROTRUSION 24
540 PHARYNGEAL OEDEMA 24
541 RASH MACULO-PAPULAR 24
542 RENAL FAILURE ACUTE 24
543 RENAL TUBULAR ACIDOSIS 24
544 STENOSIS 24
545 TASTE DISORDER 24
546 ANAEMIA MACROCYTIC 23
547 ATELECTASIS 23
548 BLOOD CHLORIDE DECREASED 23
549 BLOOD FOLLICLE STIMULATING HORMONE INCREASED 23
550 BODY TEMPERATURE INCREASED 23
551 CARDIAC DISCOMFORT 23
552 FIBROUS HISTIOCYTOMA 23
553 GASTRIC DISORDER 23
554 HUNGER 23
555 INJECTION SITE BRUISING 23
556 MUSCLE RIGIDITY 23
557 NEUTROPHIL COUNT INCREASED 23
558 ORAL PAIN 23
559 POST PROCEDURAL INFECTION 23
560 PRESCRIBED OVERDOSE 23
561 RESTLESS LEGS SYNDROME 23
562 ARTERIOSCLEROSIS 22
563 ATAXIA 22
564 CARDIAC FAILURE CHRONIC 22
565 COLITIS ULCERATIVE 22
566 ECHOCARDIOGRAM ABNORMAL 22
567 ELECTROCARDIOGRAM Q WAVE ABNORMAL 22
568 ELECTROLYTE IMBALANCE 22
569 ERUCTATION 22
570 EYE SWELLING 22
571 HAEMATOCRIT INCREASED 22
572 HEPATOJUGULAR REFLUX 22
573 HYPERSOMNIA 22
574 IRON DEFICIENCY ANAEMIA 22
575 LIVER INJURY 22
576 MUCOSAL DRYNESS 22
577 MUSCULOSKELETAL DISCOMFORT 22
578 OCCULT BLOOD 22
579 PHYSICAL EXAMINATION ABNORMAL 22
580 PNEUMONIA BACTERIAL 22
581 PROSTATE CANCER 22
582 REBOUND ACID HYPERSECRETION 22
583 SEASONAL ALLERGY 22
584 SPINAL FRACTURE 22
585 STAPHYLOCOCCAL SEPSIS 22
586 SYSTOLIC DYSFUNCTION 22
587 THROAT IRRITATION 22
588 ABSCESS 21
589 ANURIA 21
590 ARTHROPATHY 21
591 BACTERAEMIA 21
592 BLOOD PARATHYROID HORMONE INCREASED 21
593 CYTOKINE RELEASE SYNDROME 21
594 DECUBITUS ULCER 21
595 EYE DISORDER 21
596 FEEDING DISORDER 21
597 FULL BLOOD COUNT DECREASED 21
598 HAEMORRHOIDAL HAEMORRHAGE 21
599 HEPATIC CANCER 21
600 HEPATIC ENCEPHALOPATHY 21
601 INSULIN-LIKE GROWTH FACTOR DECREASED 21
602 LEFT ATRIAL DILATATION 21
603 MITRAL VALVE DISEASE 21
604 MONOCYTE COUNT INCREASED 21
605 NEOPLASM SKIN 21
606 NIGHTMARE 21
607 ODYNOPHAGIA 21
608 ORAL HERPES 21
609 PSORIATIC ARTHROPATHY 21
610 RESPIRATORY DISTRESS 21
611 RESPIRATORY RATE INCREASED 21
612 SEDATION COMPLICATION 21
613 UPPER LIMB FRACTURE 21
614 5-HYDROXYINDOLACETIC ACID INCREASED 20
615 ARTERIAL OCCLUSIVE DISEASE 20
616 BITE 20
617 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 20
618 COLD SWEAT 20
619 CONCUSSION 20
620 DIABETIC NEPHROPATHY 20
621 DRUG PRESCRIBING ERROR 20
622 DRY EYE 20
623 EYE HAEMORRHAGE 20
624 GALLBLADDER DISORDER 20
625 HALLUCINATION, VISUAL 20
626 KNEE ARTHROPLASTY 20
627 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 20
628 LACRIMATION INCREASED 20
629 MYELOSUPPRESSION 20
630 NERVE COMPRESSION 20
631 PEMPHIGUS 20
632 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 20
633 POST PROCEDURAL COMPLICATION 20
634 SCAR 20
635 TOE AMPUTATION 20
636 ACUTE MYELOID LEUKAEMIA 19
637 ANHEDONIA 19
638 BACTERIAL INFECTION 19
639 BONE DENSITY DECREASED 19
640 CARDIAC FAILURE ACUTE 19
641 CHOLANGITIS 19
642 DEVICE RELATED INFECTION 19
643 FEELING JITTERY 19
644 FREQUENT BOWEL MOVEMENTS 19
645 GINGIVAL BLEEDING 19
646 GLAUCOMA 19
647 HEAD DISCOMFORT 19
648 HYPERCALCAEMIA 19
649 LIGHT CHAIN ANALYSIS INCREASED 19
650 LIVER FUNCTION TEST INCREASED 19
651 MENTAL DISORDER 19
652 MOOD ALTERED 19
653 MYOCLONUS 19
654 NECROTISING FASCIITIS 19
655 NEOPLASM PROGRESSION 19
656 POOR QUALITY SLEEP 19
657 PSYCHOLOGICAL TRAUMA 19
658 ULCER 19
659 URINE CALCIUM/CREATININE RATIO INCREASED 19
660 ATROPHIC VULVOVAGINITIS 18
661 BLINDNESS UNILATERAL 18
662 COLON CANCER 18
663 COMA 18
664 CONCOMITANT DISEASE AGGRAVATED 18
665 DISEASE RECURRENCE 18
666 FEELING COLD 18
667 GLYCOSYLATED HAEMOGLOBIN DECREASED 18
668 HERNIA 18
669 INFARCTION 18
670 METASTASES TO BONE 18
671 MOUTH ULCERATION 18
672 NERVOUS SYSTEM DISORDER 18
673 OESOPHAGITIS 18
674 PARKINSON^S DISEASE 18
675 PERICARDIAL HAEMORRHAGE 18
676 PERITONITIS 18
677 PRODUCT AVAILABILITY ISSUE 18
678 PRODUCT DOSE OMISSION IN ERROR 18
679 PURPURA 18
680 URETHRAL CARUNCLE 18
681 ACIDOSIS 17
682 AMYLASE INCREASED 17
683 ASPERGILLUS INFECTION 17
684 BLOOD CHOLESTEROL DECREASED 17
685 CARDIOMYOPATHY 17
686 CARDIOVASCULAR DISORDER 17
687 COAGULOPATHY 17
688 CROHN^S DISEASE 17
689 DEMENTIA ALZHEIMER^S TYPE 17
690 DERMATITIS 17
691 DRUG DEPENDENCE 17
692 DRUG EFFECT INCOMPLETE 17
693 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 17
694 ERYTHEMA MULTIFORME 17
695 GASTRIC POLYPS 17
696 HEPATITIS 17
697 HYPERVOLAEMIA 17
698 ILEUS 17
699 LOW DENSITY LIPOPROTEIN INCREASED 17
700 LYMPHADENOPATHY 17
701 METASTASES TO LIVER 17
702 MUSCLE ATROPHY 17
703 MUSCLE TIGHTNESS 17
704 PAIN IN JAW 17
705 PNEUMOCYSTIS JIROVECII PNEUMONIA 17
706 RENAL CANCER 17
707 RESPIRATORY TRACT CONGESTION 17
708 SINUS CONGESTION 17
709 SMALL INTESTINAL OBSTRUCTION 17
710 THERAPY NON-RESPONDER 17
711 WRIST FRACTURE 17
712 ACCIDENTAL EXPOSURE TO PRODUCT 16
713 BLOOD ALBUMIN DECREASED 16
714 BLOOD MAGNESIUM DECREASED 16
715 DEAFNESS 16
716 DELUSION 16
717 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 16
718 FAILURE TO THRIVE 16
719 HYPERURICAEMIA 16
720 HYPOTONIA 16
721 INCREASED APPETITE 16
722 IRRITABLE BOWEL SYNDROME 16
723 KIDNEY TRANSPLANT REJECTION 16
724 LOWER GASTROINTESTINAL HAEMORRHAGE 16
725 MACULAR DEGENERATION 16
726 MOTOR DYSFUNCTION 16
727 ORAL MUCOSAL BLISTERING 16
728 POOR VENOUS ACCESS 16
729 RENAL PAIN 16
730 ROTATOR CUFF SYNDROME 16
731 SINUS DISORDER 16
732 SPINAL PAIN 16
733 THYROID DISORDER 16
734 TOXIC SKIN ERUPTION 16
735 TRANSFUSION 16
736 ABNORMAL DREAMS 15
737 ANAL INCONTINENCE 15
738 ANGER 15
739 BLOOD PRESSURE DIASTOLIC INCREASED 15
740 BLOOD THYROID STIMULATING HORMONE INCREASED 15
741 BRONCHIAL HYPERREACTIVITY 15
742 DYSLIPIDAEMIA 15
743 ECONOMIC PROBLEM 15
744 FOOT FRACTURE 15
745 GASTRIC HAEMORRHAGE 15
746 GASTROINTESTINAL HYPOMOTILITY 15
747 HEPATOTOXICITY 15
748 IMPAIRED HEALING 15
749 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 15
750 INITIAL INSOMNIA 15
751 JOINT DISLOCATION 15
752 LIGAMENT SPRAIN 15
753 LOWER LIMB FRACTURE 15
754 OBESITY 15
755 ONYCHOCLASIS 15
756 PANCREATIC DISORDER 15
757 PNEUMOTHORAX 15
758 POLYNEUROPATHY 15
759 PRESCRIBED UNDERDOSE 15
760 PRODUCT DISPENSING ERROR 15
761 RENAL CYST 15
762 RESPIRATORY SYMPTOM 15
763 SUSPECTED SUICIDE 15
764 TOOTHACHE 15
765 ABASIA 14
766 ACUTE LUNG INJURY 14
767 APLASIA PURE RED CELL 14
768 ASTERIXIS 14
769 BLINDNESS TRANSIENT 14
770 BLOOD CALCIUM DECREASED 14
771 BLOOD URINE PRESENT 14
772 CANDIDA INFECTION 14
773 CHOLESTATIC LIVER INJURY 14
774 CRYING 14
775 CYSTOSTOMY 14
776 DEVICE LEAKAGE 14
777 DIABETIC METABOLIC DECOMPENSATION 14
778 DRUG ADMINISTRATION ERROR 14
779 DRUG LEVEL DECREASED 14
780 DUODENAL ULCER 14
781 ECCHYMOSIS 14
782 ERECTILE DYSFUNCTION 14
783 FACE OEDEMA 14
784 FACIAL PARALYSIS 14
785 FOOD ALLERGY 14
786 GLOMERULONEPHRITIS MEMBRANOUS 14
787 HEART RATE ABNORMAL 14
788 HOSPICE CARE 14
789 HYPOAESTHESIA ORAL 14
790 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 14
791 INABILITY TO AFFORD MEDICATION 14
792 INJECTION SITE NODULE 14
793 INTENTIONAL DOSE OMISSION 14
794 METABOLIC ENCEPHALOPATHY 14
795 NEUTROPHILIA 14
796 PRODUCT STORAGE ERROR 14
797 PROSTATIC SPECIFIC ANTIGEN INCREASED 14
798 PULMONARY ARTERIAL HYPERTENSION 14
799 PULMONARY FIBROSIS 14
800 RED CELL DISTRIBUTION WIDTH INCREASED 14
801 RESPIRATORY DISORDER 14
802 RESTLESSNESS 14
803 SEDATION 14
804 SHOULDER FRACTURE 14
805 SKIN BURNING SENSATION 14
806 SKIN INFECTION 14
807 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 14
808 TENDERNESS 14
809 TENDONITIS 14
810 THYROID CANCER 14
811 TREATMENT FAILURE 14
812 TROPONIN INCREASED 14
813 ALBUMINURIA 13
814 ATRIOVENTRICULAR BLOCK FIRST DEGREE 13
815 BILE DUCT STONE 13
816 BRADYKINESIA 13
817 DECREASED ACTIVITY 13
818 DEVICE MALFUNCTION 13
819 EOSINOPHIL COUNT INCREASED 13
820 EOSINOPHILIC PNEUMONIA 13
821 GLOSSODYNIA 13
822 GLYCOSYLATED HAEMOGLOBIN ABNORMAL 13
823 HEART FAILURE WITH REDUCED EJECTION FRACTION 13
824 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 13
825 HYPOPHOSPHATAEMIA 13
826 HYPOTHERMIA 13
827 INCORRECT DOSE ADMINISTERED BY DEVICE 13
828 INFUSION RELATED REACTION 13
829 LACERATION 13
830 LUNG INFILTRATION 13
831 LYMPHOMA 13
832 MOOD SWINGS 13
833 MYOCARDIAL ISCHAEMIA 13
834 MYOPATHY 13
835 NEUROGLYCOPENIA 13
836 NEUTROPENIC SEPSIS 13
837 ORAL DISCOMFORT 13
838 OSTEOPENIA 13
839 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 13
840 PERIPHERAL ARTERY OCCLUSION 13
841 POTENTIATING DRUG INTERACTION 13
842 PRODUCT PRESCRIBING ISSUE 13
843 PSYCHOTIC DISORDER 13
844 RENAL FUNCTION TEST ABNORMAL 13
845 RETINAL DETACHMENT 13
846 RHINALGIA 13
847 SKIN CANCER 13
848 SKIN HAEMORRHAGE 13
849 SPINAL COMPRESSION FRACTURE 13
850 STUPOR 13
851 SUICIDAL IDEATION 13
852 THERAPEUTIC RESPONSE SHORTENED 13
853 ACCIDENT 12
854 ARTHRITIS BACTERIAL 12
855 BONE DISORDER 12
856 CARDIOGENIC SHOCK 12
857 CHOLECYSTITIS ACUTE 12
858 CIRCULATORY COLLAPSE 12
859 COELIAC DISEASE 12
860 CYST 12
861 DERMATITIS ALLERGIC 12
862 DISABILITY 12
863 DISTRIBUTIVE SHOCK 12
864 DIZZINESS POSTURAL 12
865 DRUG EFFECT DECREASED 12
866 DRUG LEVEL BELOW THERAPEUTIC 12
867 EAR PAIN 12
868 FEMORAL NECK FRACTURE 12
869 FORMICATION 12
870 GASTRIC CANCER 12
871 HAEMODIALYSIS 12
872 HEPATOCELLULAR CARCINOMA 12
873 HICCUPS 12
874 HYPERKERATOSIS 12
875 HYPERTHYROIDISM 12
876 HYPOKINESIA 12
877 IMMUNE-MEDIATED LUNG DISEASE 12
878 IMMUNE-MEDIATED MYOSITIS 12
879 INTERVERTEBRAL DISC DEGENERATION 12
880 MASS 12
881 MENTAL STATUS CHANGES 12
882 METASTASES TO LUNG 12
883 MUSCULOSKELETAL DISORDER 12
884 MYELODYSPLASTIC SYNDROME 12
885 NECROSIS 12
886 NEURALGIA 12
887 OESOPHAGEAL VARICES HAEMORRHAGE 12
888 OSTEONECROSIS 12
889 PAROSMIA 12
890 PERIPHERAL COLDNESS 12
891 PRE-EXISTING CONDITION IMPROVED 12
892 PRODUCT SUBSTITUTION ISSUE 12
893 PSEUDOMONAS INFECTION 12
894 SKIN LACERATION 12
895 THERAPEUTIC PRODUCT EFFECT DECREASED 12
896 TOOTH DISORDER 12
897 VAGINAL HAEMORRHAGE 12
898 WALKING AID USER 12
899 WEIGHT FLUCTUATION 12
900 WRONG TECHNIQUE IN DRUG USAGE PROCESS 12
901 ACCIDENTAL UNDERDOSE 11
902 ACUTE CORONARY SYNDROME 11
903 ANGINA UNSTABLE 11
904 AORTIC STENOSIS 11
905 AORTIC VALVE STENOSIS 11
906 ASPHYXIA 11
907 BENIGN PROSTATIC HYPERPLASIA 11
908 BLOOD CREATININE ABNORMAL 11
909 BLOOD IMMUNOGLOBULIN E INCREASED 11
910 BLOOD URIC ACID INCREASED 11
911 CARDIAC OPERATION 11
912 CARPAL TUNNEL SYNDROME 11
913 CHOKING 11
914 COLITIS ISCHAEMIC 11
915 DIABETIC RETINOPATHY 11
916 DRUG LEVEL ABOVE THERAPEUTIC 11
917 ENDOCARDITIS 11
918 ENTEROCOLITIS 11
919 EPILEPSY 11
920 FEAR 11
921 FOOT DEFORMITY 11
922 FORCED EXPIRATORY VOLUME DECREASED 11
923 FRACTURE 11
924 FULL BLOOD COUNT ABNORMAL 11
925 GROIN PAIN 11
926 HAEMOGLOBIN ABNORMAL 11
927 HEMIPARESIS 11
928 HYDROCEPHALUS 11
929 HYPERBILIRUBINAEMIA 11
930 INCORRECT DRUG ADMINISTRATION DURATION 11
931 INJECTION SITE REACTION 11
932 JOINT STIFFNESS 11
933 MULTIPLE DRUG THERAPY 11
934 MYCOPLASMA INFECTION 11
935 NIGHT SWEATS 11
936 PANCREATIC ENZYMES INCREASED 11
937 PARANOIA 11
938 PELVIC PAIN 11
939 PERIPHERAL CIRCULATORY FAILURE 11
940 PHARYNGEAL SWELLING 11
941 PHYSICAL DECONDITIONING 11
942 PRODUCT ADMINISTRATION ERROR 11
943 PROTEIN TOTAL DECREASED 11
944 SNEEZING 11
945 SPINAL OSTEOARTHRITIS 11
946 TRANSAMINASES INCREASED 11
947 TROPONIN T INCREASED 11
948 URETERIC HAEMORRHAGE 11
949 VARICES OESOPHAGEAL 11
950 WOUND SECRETION 11
951 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 11
952 AFFECT LABILITY 10
953 ANAL ABSCESS 10
954 ANKYLOSING SPONDYLITIS 10
955 BASAL CELL CARCINOMA 10
956 BREAST PAIN 10
957 BRONCHIECTASIS 10
958 BRONCHITIS VIRAL 10
959 CARDIAC PACEMAKER INSERTION 10
960 CHOKING SENSATION 10
961 COMPARTMENT SYNDROME 10
962 COMPRESSION FRACTURE 10
963 DEFAECATION URGENCY 10
964 DIVERTICULUM 10
965 DYSTONIA 10
966 EMOTIONAL DISORDER 10
967 ENTHESOPATHY 10
968 EXTRAPYRAMIDAL DISORDER 10
969 EYE INFECTION 10
970 EYELID OEDEMA 10
971 FIBROMYALGIA 10
972 FLUID OVERLOAD 10
973 GLUCOSE URINE PRESENT 10
974 HYPERNATRAEMIA 10
975 HYPERTENSIVE CRISIS 10
976 HYPERTRIGLYCERIDAEMIA 10
977 HYPOALBUMINAEMIA 10
978 INFUSION SITE PAIN 10
979 JOINT DESTRUCTION 10
980 JOINT LOCK 10
981 LEFT VENTRICULAR FAILURE 10
982 LYMPHOPENIA 10
983 MALIGNANT MELANOMA 10
984 PANCREATIC CARCINOMA METASTATIC 10
985 PARALYSIS 10
986 PERIPHERAL ISCHAEMIA 10
987 PERITONEAL HAEMATOMA 10
988 PHOTOPHOBIA 10
989 PLATELET COUNT INCREASED 10
990 PRODUCT SUPPLY ISSUE 10
991 PULMONARY FUNCTION TEST ABNORMAL 10
992 RESPIRATORY ARREST 10
993 SARS-COV-2 TEST POSITIVE 10
994 SCAB 10
995 SCHIZOPHRENIA 10
996 SCRATCH 10
997 SENSITIVITY TO WEATHER CHANGE 10
998 SKIN ABRASION 10
999 SKIN REACTION 10